27 related articles for article (PubMed ID: 37916628)
21. Transcriptional Regulation of CYP2D6 Expression.
Pan X; Ning M; Jeong H
Drug Metab Dispos; 2017 Jan; 45(1):42-48. PubMed ID: 27698228
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 Regulates the Expression of
Siswanto FM; Handayani MDN; Firmasyah RD; Oguro A; Imaoka S
Curr Drug Metab; 2023; 24(9):667-681. PubMed ID: 37916628
[TBL] [Abstract][Full Text] [Related]
24. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.
He ZX; Chen XW; Zhou ZW; Zhou SF
Drug Metab Rev; 2015; 47(4):470-519. PubMed ID: 26574146
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology.
Kasai S; Shimizu S; Tatara Y; Mimura J; Itoh K
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32079324
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
Ur Rasheed MS; Mishra AK; Singh MP
Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
Haque E; Karim MR; Salam Teeli A; Ĺmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]